…nd corticosteroids, with relapses occurring in 20–50% of cases. Rituximab and caplacizumab (available since 2018) are currently used in c…
Rituximab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Rituximab
201 articles · page 3 of 17…iated with lupus nephritis; these may predict renal response to rituximab treatment.…
… class IV. She was treated with pulse IV Solumedrol followed by prednisone taper, HCQ, MMF and later one, MMF was switched to azathioprine…
…plained approximately 8% of the variance in δCLASI (R2 = 0.08). Anifrolumab was the only therapy independently associated with significant …
…ntation in 2014, he was on hydroxychloroquine, methotrexate and coumadin with a therapeutic INR. His testicular Doppler ultrasound was s…
…atients were enrolled based on published data supporting use of rituximab or tocilizumab. Each arm aimed to enroll 15 patients. Primary e…
…different immunosuppressive agents, sometimes with no response. Rituximab has been emerging as an alternative therapeutic option.We descr…
…es.New arthritis focussed trials have been evaluated, including Rituximab Objective Outcome measures Trial in SLE (ROOTS) that combines a…
…1.38), TNFi 1.01 (0.66 to 1.54), rituximab 1.14 (0.71 to 1.84), tocilizumab 1.48 (0.92 to 2.40). LDA and remission rates were unaffected by…
…nt started a b/tsDMARD (abatacept: 242, IL-6Ri: 317, JAKi: 333, rituximab: 176, TNFi: 874). Compared with the wrist, all joints demonstra…
…lation with the skin score(r=-0.271) and with the total dose of rituximab(r=-0.38) was established.There was no correlation between the i…
… fibrin, but no active infection or granuloma.Results Following Rituximab and subsequent initiation of mycophenolate mofetil (MMF), there…